Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer
- Resource Type
- Journal
- Source
JOURNAL OF CLINICAL ONCOLOGY ; SEP 10 2006, 24 26, p4245-p4253, 9p.- Subject
- Language
- English
- ISSN
- 0732183X